Aims to support early-stage companies that are working to solve important healthcare needs|Andy Schwab,Managing Partner,5AM Ventures 00:10:00
Prior to founding 5AM in 2002, Mr. Schwab was a Principal at Bay City Capital where he was involved with companies such as Cubist, PTC Therapeutics and Syrrx. Previously Mr. Schwab was Vice President of Business Development at Digital Gene Technologies and a Vice President in the life science investment banking group of Montgomery Securities.